{"id":"https://openalex.org/W7212384162","doi":"https://doi.org/10.64898/2026.09.08.26362402","title":"Drug\u2013Drug Interaction Signals Between Anti-Amyloid-\u03b2 Antibodies and Antithrombotic Drugs for Amyloid-Related Imaging Abnormalities and Intracranial Hemorrhage: A FAERS Disproportionality Analysis","display_name":"Drug\u2013Drug Interaction Signals Between Anti-Amyloid-\u03b2 Antibodies and Antithrombotic Drugs for Amyloid-Related Imaging Abnormalities and Intracranial Hemorrhage: A FAERS Disproportionality Analysis","publication_year":2026,"publication_date":"2026-09-11","ids":{"openalex":"https://openalex.org/W7212384162","doi":"https://doi.org/10.64898/2026.09.08.26362402"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.08.26362402","doi":"https://doi.org/10.64898/2026.09.08.26362402","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.08.26362402","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/11/2026.09.08.26362402.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/11/2026.09.08.26362402.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5134579760","display_name":"Tsuyoshi Nakai","orcid":"https://orcid.org/0009-0005-2667-7057","observed_orcids":["https://orcid.org/0009-0005-2667-7057"]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tsuyoshi Nakai","raw_affiliation_strings":["Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan"],"raw_orcid":"https://orcid.org/0009-0005-2667-7057","affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan","institution_ids":["https://openalex.org/I145673806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062024076","display_name":"Takenao Koseki","orcid":"https://orcid.org/0000-0002-2889-9586","observed_orcids":["https://orcid.org/0000-0002-2889-9586"]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takenao Koseki","raw_affiliation_strings":["Department of Advanced Medical Professional Development, Fujita Health University School of Medical Sciences, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan","Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan"],"raw_orcid":"https://orcid.org/0000-0002-2889-9586","affiliations":[{"raw_affiliation_string":"Department of Advanced Medical Professional Development, Fujita Health University School of Medical Sciences, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan","institution_ids":["https://openalex.org/I145673806"]},{"raw_affiliation_string":"Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan","institution_ids":["https://openalex.org/I145673806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010867165","display_name":"Hirohisa Watanabe","orcid":"https://orcid.org/0000-0001-8553-8536","observed_orcids":["https://orcid.org/0000-0001-8553-8536"]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirohisa Watanabe","raw_affiliation_strings":["Department of Neurology, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan"],"raw_orcid":"https://orcid.org/0000-0001-8553-8536","affiliations":[{"raw_affiliation_string":"Department of Neurology, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan","institution_ids":["https://openalex.org/I145673806"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029952836","display_name":"Shigeki Yamada","orcid":"https://orcid.org/0000-0001-7158-5569","observed_orcids":["https://orcid.org/0000-0001-7158-5569"]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeki Yamada","raw_affiliation_strings":["Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1\u201398 Dengakugakubo, Kutsukake-cho, Toyoake 470\u20131192, Aichi, Japan","institution_ids":["https://openalex.org/I145673806"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5134579760"],"corresponding_institution_ids":["https://openalex.org/I145673806"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.07909999787807465,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8460000157356262},{"id":"https://openalex.org/keywords/anti-amyloid-beta-antibodies","display_name":"anti-amyloid beta antibodies","score":0.8700000047683716},{"id":"https://openalex.org/keywords/amyloid-related-imaging-abnormalities","display_name":"amyloid-related imaging abnormalities","score":0.878000020980835},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9929999709129333},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.6940000057220459},{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.8870000243186951},{"id":"https://openalex.org/keywords/lecanemab","display_name":"lecanemab","score":0.878000020980835},{"id":"https://openalex.org/keywords/aducanumab","display_name":"aducanumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/donanemab","display_name":"donanemab","score":1.0},{"id":"https://openalex.org/keywords/antithrombotic-agents","display_name":"antithrombotic agents","score":0.8339999914169312},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8330000042915344},{"id":"https://openalex.org/keywords/drug-safety-signals","display_name":"drug safety signals","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8784000277519226},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.6851000189781189},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.5788999795913696},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.49970000982284546},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.4733999967575073},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46779999136924744},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.40560001134872437},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.3889000117778778},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.37619999051094055},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.32440000772476196},{"id":"https://openalex.org/C2779581417","wikidata":"https://www.wikidata.org/wiki/Q1931577","display_name":"Thrombolysis","level":3,"score":0.3086000084877014},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.30309998989105225},{"id":"https://openalex.org/C2909817843","wikidata":"https://www.wikidata.org/wiki/Q575222","display_name":"Fibrinolytic agent","level":3,"score":0.3028999865055084},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.289000004529953},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2782000005245209},{"id":"https://openalex.org/C2777094939","wikidata":"https://www.wikidata.org/wiki/Q1368943","display_name":"Intracerebral hemorrhage","level":3,"score":0.2678999900817871},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.26260000467300415},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26030001044273376},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.25780001282691956},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.25}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.08.26362402","doi":"https://doi.org/10.64898/2026.09.08.26362402","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.08.26362402","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/11/2026.09.08.26362402.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.08.26362402","doi":"https://doi.org/10.64898/2026.09.08.26362402","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.08.26362402","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/11/2026.09.08.26362402.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7212384162.pdf","grobid_xml":"https://content.openalex.org/works/W7212384162.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W2015487160","https://openalex.org/W2038397660","https://openalex.org/W2064716383","https://openalex.org/W2095177832","https://openalex.org/W2098730643","https://openalex.org/W2108216694","https://openalex.org/W2116163670","https://openalex.org/W2120520848","https://openalex.org/W2589851064","https://openalex.org/W2591658037","https://openalex.org/W2988170839","https://openalex.org/W3023436560","https://openalex.org/W3215241365","https://openalex.org/W4206046172","https://openalex.org/W4225741213","https://openalex.org/W4291010256","https://openalex.org/W4310461604","https://openalex.org/W4313546276","https://openalex.org/W4360591479","https://openalex.org/W4379600618","https://openalex.org/W4384522480","https://openalex.org/W4396696202","https://openalex.org/W4396804148","https://openalex.org/W4406159212","https://openalex.org/W4406268247","https://openalex.org/W4408290084","https://openalex.org/W4408417672","https://openalex.org/W4408988700","https://openalex.org/W4409074558","https://openalex.org/W4410481172","https://openalex.org/W4413304387","https://openalex.org/W4413313101","https://openalex.org/W4414441550","https://openalex.org/W7164880850"],"related_works":["https://openalex.org/W7171702328","https://openalex.org/W7126152331","https://openalex.org/W4411494025","https://openalex.org/W7117256091","https://openalex.org/W7116955058","https://openalex.org/W4406995009","https://openalex.org/W7168034261","https://openalex.org/W4391033321","https://openalex.org/W7210269716","https://openalex.org/W7116904833"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Anti-amyloid-\u03b2":[2],"(A\u03b2)":[3],"monoclonal":[4],"antibodies":[5,44,73,133,143],"are":[6,14],"disease-modifying":[7],"treatments":[8],"for":[9,48,137,152,165,207,211,217],"early":[10],"Alzheimer\u2019s":[11],"disease":[12],"but":[13],"associated":[15],"with":[16,100,106,182,220,237],"amyloid-related":[17],"imaging":[18],"abnormalities":[19],"(ARIA)":[20],"and":[21,45,50,78,90,110,120,156,168,184,213,231,235],"intracranial":[22],"hemorrhage":[23],"(ICH).":[24],"However,":[25],"the":[26,53,141,186,197],"safety":[27],"of":[28,228],"concomitant":[29],"antithrombotic":[30,46],"use":[31],"remains":[32],"unclear.":[33],"Objective":[34],"To":[35],"evaluate":[36],"potential":[37],"drug\u2013drug":[38],"interaction":[39],"(DDI)":[40],"signals":[41,113,136,151,164,177,204],"between":[42],"anti-A\u03b2":[43,72,190,208,214,240],"drugs":[47],"ARIA":[49,99,105,167,212],"ICH":[51],"using":[52,116,126],"FDA":[54],"Adverse":[55],"Event":[56],"Reporting":[57],"System":[58],"(FAERS;":[59],"JAPIC":[60],"AERS).":[61],"Methods":[62],"FAERS":[63],"reports":[64],"from":[65],"1997":[66],"to":[67],"2024":[68],"were":[69,75,81,96,114,124,144,194,205],"analyzed.":[70],"The":[71],"evaluated":[74,125],"aducanumab,":[76],"lecanemab,":[77],"donanemab.":[79],"Antithrombotics":[80],"aspirin,":[82],"P2Y":[83],"12":[84],"inhibitors,":[85],"direct":[86],"oral":[87],"anticoagulants,":[88],"warfarin,":[89],"tissue-type":[91],"plasminogen":[92],"activators":[93],"(tPAs).":[94],"Outcomes":[95],"any":[97,153,166],"ARIA,":[98,154],"edema":[101],"or":[102],"effusion":[103],"(ARIA-E),":[104],"hemosiderin":[107],"deposition":[108],"(ARIA-H),":[109],"ICH.":[111],"Individual-drug":[112],"assessed":[115],"reporting":[117],"odds":[118],"ratios":[119],"information":[121],"components;":[122],"DDIs":[123],"four":[127,180],"complementary":[128],"models.":[129,160,172],"Results":[130],"All":[131],"three":[132,142,159],"showed":[134,148,163,176],"positive":[135,149],"all":[138,179,189],"outcomes.":[139],"When":[140],"analyzed":[145],"together,":[146],"aspirin":[147,229],"DDI":[150,203],"ARIA-E,":[155],"ARIA-H":[157,169],"in":[158,170,178,185],"Lecanemab\u2013aspirin":[161],"also":[162],"multiple":[171],"For":[173],"ICH,":[174,218],"tPAs":[175],"models":[181],"lecanemab":[183,200],"analysis":[187],"combining":[188],"antibodies.":[191],"Both":[192],"analyses":[193],"based":[195],"on":[196],"same":[198],"five":[199],"reports.":[201],"Conclusions":[202],"detected":[206],"antibody\u2013aspirin":[209],"combinations":[210,216],"antibody\u2013tPA":[215],"particularly":[219],"lecanemab.":[221],"These":[222],"findings":[223],"may":[224],"warrant":[225],"careful":[226],"review":[227],"indications":[230],"baseline":[232],"hemorrhagic":[233],"risk":[234],"caution":[236],"thrombolysis":[238],"during":[239],"antibody":[241],"treatment,":[242],"although":[243],"prospective":[244],"validation":[245],"is":[246],"needed.":[247]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-13T00:00:00"}